Cargando…
ErbB3 plays a key role in the early phase of establishment of resistance to BRAF and/or MEK inhibitors
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315234/ http://dx.doi.org/10.1186/1479-5876-13-S1-K3 |
_version_ | 1782355442621480960 |
---|---|
author | Fattore, Luigi Malpicci, Debora Marra, Emanuele Camerlingo, Rosalba Roscilli, Giuseppe Belleudi, Francesca Ribas, Antoni Mancini, Rita Torrisi, Maria Rosaria Aurisicchio, Luigi Ascierto, Paolo Antonio Ciliberto, Gennaro |
author_facet | Fattore, Luigi Malpicci, Debora Marra, Emanuele Camerlingo, Rosalba Roscilli, Giuseppe Belleudi, Francesca Ribas, Antoni Mancini, Rita Torrisi, Maria Rosaria Aurisicchio, Luigi Ascierto, Paolo Antonio Ciliberto, Gennaro |
author_sort | Fattore, Luigi |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4315234 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-43152342015-02-12 ErbB3 plays a key role in the early phase of establishment of resistance to BRAF and/or MEK inhibitors Fattore, Luigi Malpicci, Debora Marra, Emanuele Camerlingo, Rosalba Roscilli, Giuseppe Belleudi, Francesca Ribas, Antoni Mancini, Rita Torrisi, Maria Rosaria Aurisicchio, Luigi Ascierto, Paolo Antonio Ciliberto, Gennaro J Transl Med Keynote Speaker Presentation BioMed Central 2015-01-15 /pmc/articles/PMC4315234/ http://dx.doi.org/10.1186/1479-5876-13-S1-K3 Text en Copyright © 2015 Fattore et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Keynote Speaker Presentation Fattore, Luigi Malpicci, Debora Marra, Emanuele Camerlingo, Rosalba Roscilli, Giuseppe Belleudi, Francesca Ribas, Antoni Mancini, Rita Torrisi, Maria Rosaria Aurisicchio, Luigi Ascierto, Paolo Antonio Ciliberto, Gennaro ErbB3 plays a key role in the early phase of establishment of resistance to BRAF and/or MEK inhibitors |
title | ErbB3 plays a key role in the early phase of establishment of resistance to BRAF and/or MEK inhibitors |
title_full | ErbB3 plays a key role in the early phase of establishment of resistance to BRAF and/or MEK inhibitors |
title_fullStr | ErbB3 plays a key role in the early phase of establishment of resistance to BRAF and/or MEK inhibitors |
title_full_unstemmed | ErbB3 plays a key role in the early phase of establishment of resistance to BRAF and/or MEK inhibitors |
title_short | ErbB3 plays a key role in the early phase of establishment of resistance to BRAF and/or MEK inhibitors |
title_sort | erbb3 plays a key role in the early phase of establishment of resistance to braf and/or mek inhibitors |
topic | Keynote Speaker Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315234/ http://dx.doi.org/10.1186/1479-5876-13-S1-K3 |
work_keys_str_mv | AT fattoreluigi erbb3playsakeyroleintheearlyphaseofestablishmentofresistancetobrafandormekinhibitors AT malpiccidebora erbb3playsakeyroleintheearlyphaseofestablishmentofresistancetobrafandormekinhibitors AT marraemanuele erbb3playsakeyroleintheearlyphaseofestablishmentofresistancetobrafandormekinhibitors AT camerlingorosalba erbb3playsakeyroleintheearlyphaseofestablishmentofresistancetobrafandormekinhibitors AT roscilligiuseppe erbb3playsakeyroleintheearlyphaseofestablishmentofresistancetobrafandormekinhibitors AT belleudifrancesca erbb3playsakeyroleintheearlyphaseofestablishmentofresistancetobrafandormekinhibitors AT ribasantoni erbb3playsakeyroleintheearlyphaseofestablishmentofresistancetobrafandormekinhibitors AT mancinirita erbb3playsakeyroleintheearlyphaseofestablishmentofresistancetobrafandormekinhibitors AT torrisimariarosaria erbb3playsakeyroleintheearlyphaseofestablishmentofresistancetobrafandormekinhibitors AT aurisicchioluigi erbb3playsakeyroleintheearlyphaseofestablishmentofresistancetobrafandormekinhibitors AT asciertopaoloantonio erbb3playsakeyroleintheearlyphaseofestablishmentofresistancetobrafandormekinhibitors AT cilibertogennaro erbb3playsakeyroleintheearlyphaseofestablishmentofresistancetobrafandormekinhibitors |